Research & Studies: CBD for Depression
Here is a list of research and studies on CBD and it’s potential use for treating Depression.
CBD for Depression:
- Antidepressant-like and anxiolytic-like effects of cannabidiol
- Endocannabinoid system dysfunction in mood and related disorders.
- Endocannabinoid signaling in the etiology and treatment of major depressive illness
- The endocannabinoid system and the treatment of mood and anxiety disorders.
- Antidepressant-like effects of cannabidiol in mice
- Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
- Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
- Serum contents of endocannabinoids are correlated with blood pressure in depressed women.
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
- The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
- Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.
- Prohedonic Effect of Cannabidiol in a Rat Model of Depression.
IMPORTANT: Most of these studies involve cannabinoid molecules, experimental animals, test tubes, and sometimes human cell-lined studies. It’s important to understand that the Endocannabinoid System exists in all mammals including dogs, cats, rabbits, horses, and humans. CBD affects us in the same way that it affects our pets.